PDB Short entry for 3D4Q HEADER TRANSFERASE 14-MAY-08 3D4Q TITLE PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 432-726; COMPND 5 SYNONYM: P94, V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HI-5; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, ATP-BINDING, CARDIOMYOPATHY, DISEASE MUTATION, METAL-BINDING, KEYWDS 2 NUCLEOTIDE-BINDING, PHORBOL-ESTER BINDING, PHOSPHOPROTEIN, PROTO- KEYWDS 3 ONCOGENE, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR T.MORALES,G.P.A.VIGERS,B.J.BRANDHUBER REVDAT 4 24-JAN-18 3D4Q 1 AUTHOR REVDAT 3 08-SEP-10 3D4Q 1 SOURCE REVDAT 2 24-FEB-09 3D4Q 1 VERSN REVDAT 1 19-AUG-08 3D4Q 0 JRNL AUTH J.D.HANSEN,J.GRINA,B.NEWHOUSE,M.WELCH,G.TOPALOV,N.LITTMAN, JRNL AUTH 2 M.CALLEJO,S.GLOOR,M.MARTINSON,E.LAIRD,B.J.BRANDHUBER, JRNL AUTH 3 G.VIGERS,T.MORALES,R.WOESSNER,N.RANDOLPH,J.LYSSIKATOS, JRNL AUTH 4 A.OLIVERO JRNL TITL POTENT AND SELECTIVE PYRAZOLE-BASED INHIBITORS OF B-RAF JRNL TITL 2 KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 4692 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18676143 JRNL DOI 10.1016/J.BMCL.2008.07.002 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 20642 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1002 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 23 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18900 REMARK 3 B22 (A**2) : -0.18900 REMARK 3 B33 (A**2) : 0.37800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.020 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : AR00384000.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3D4Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1000047589. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20661 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.7 REMARK 200 DATA REDUNDANCY : 8.800 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.4 REMARK 200 DATA REDUNDANCY IN SHELL : 8.90 REMARK 200 R MERGE FOR SHELL (I) : 0.40800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG 3350 0.1M TRIS 10% TACSIMATE, REMARK 280 PH 7.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 285K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.26800 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 50.17150 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 50.17150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.63400 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 50.17150 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 50.17150 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 121.90200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 50.17150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.17150 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.63400 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 50.17150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.17150 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 121.90200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.26800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 420 REMARK 465 ASP A 421 REMARK 465 ARG A 422 REMARK 465 GLY A 423 REMARK 465 SER A 424 REMARK 465 HIS A 425 REMARK 465 HIS A 426 REMARK 465 HIS A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 465 GLY A 431 REMARK 465 SER A 432 REMARK 465 GLU A 433 REMARK 465 ASP A 434 REMARK 465 ARG A 435 REMARK 465 ASN A 436 REMARK 465 ARG A 437 REMARK 465 MET A 438 REMARK 465 LYS A 439 REMARK 465 THR A 440 REMARK 465 LEU A 441 REMARK 465 GLY A 442 REMARK 465 ARG A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 ILE A 724 REMARK 465 HIS A 725 REMARK 465 ARG A 726 REMARK 465 MET B 420 REMARK 465 ASP B 421 REMARK 465 ARG B 422 REMARK 465 GLY B 423 REMARK 465 SER B 424 REMARK 465 HIS B 425 REMARK 465 HIS B 426 REMARK 465 HIS B 427 REMARK 465 HIS B 428 REMARK 465 HIS B 429 REMARK 465 HIS B 430 REMARK 465 GLY B 431 REMARK 465 SER B 432 REMARK 465 GLU B 433 REMARK 465 ASP B 434 REMARK 465 ARG B 435 REMARK 465 ASN B 436 REMARK 465 ARG B 437 REMARK 465 MET B 438 REMARK 465 LYS B 439 REMARK 465 THR B 440 REMARK 465 LEU B 441 REMARK 465 GLY B 442 REMARK 465 ARG B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 ILE B 724 REMARK 465 HIS B 725 REMARK 465 ARG B 726 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 501 O28 SM5 A 1 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 523 C - N - CA ANGL. DEV. = -13.1 DEGREES REMARK 500 PRO B 523 C - N - CA ANGL. DEV. = -14.3 DEGREES REMARK 500 PRO B 632 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 449 160.31 -43.33 REMARK 500 THR A 488 -29.24 61.85 REMARK 500 ALA A 489 132.11 137.11 REMARK 500 THR A 491 156.43 -45.62 REMARK 500 LEU A 514 130.06 -36.16 REMARK 500 GLN A 530 156.02 -49.12 REMARK 500 ASP A 576 33.96 -155.27 REMARK 500 LYS A 578 163.71 178.49 REMARK 500 GLU A 586 23.31 48.90 REMARK 500 ASP A 587 -4.02 59.92 REMARK 500 ASP A 594 95.94 67.73 REMARK 500 SER A 614 137.47 -176.28 REMARK 500 SER A 616 -69.99 -92.13 REMARK 500 ILE A 617 -39.44 81.10 REMARK 500 MET A 627 81.23 -43.35 REMARK 500 ASP A 629 -158.72 -153.82 REMARK 500 TYR A 656 31.92 73.45 REMARK 500 PRO A 722 -6.23 -55.60 REMARK 500 ASP B 449 164.86 -40.55 REMARK 500 GLN B 461 125.63 -36.56 REMARK 500 THR B 488 -32.53 61.73 REMARK 500 ALA B 489 133.89 142.37 REMARK 500 THR B 491 157.29 -48.18 REMARK 500 HIS B 510 131.18 -171.48 REMARK 500 GLN B 530 154.70 -49.95 REMARK 500 ASP B 576 33.86 -152.40 REMARK 500 LYS B 578 159.70 176.42 REMARK 500 ASP B 587 -5.45 60.20 REMARK 500 ASP B 594 97.83 64.55 REMARK 500 SER B 614 137.66 -176.80 REMARK 500 SER B 616 -67.47 -95.43 REMARK 500 ILE B 617 -41.16 80.91 REMARK 500 MET B 627 83.62 -43.40 REMARK 500 ASP B 629 -158.31 -155.21 REMARK 500 PRO B 722 -6.54 -56.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 485 ASN A 486 -142.46 REMARK 500 ASN A 486 VAL A 487 133.98 REMARK 500 LEU B 485 ASN B 486 -139.78 REMARK 500 ASN B 486 VAL B 487 134.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SM5 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SM5 B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PSB RELATED DB: PDB REMARK 900 RELATED ID: 3PSD RELATED DB: PDB DBREF 3D4Q A 433 726 UNP P15056 BRAF1_HUMAN 433 726 DBREF 3D4Q B 433 726 UNP P15056 BRAF1_HUMAN 433 726 SEQADV 3D4Q MET A 420 UNP P15056 EXPRESSION TAG SEQADV 3D4Q ASP A 421 UNP P15056 EXPRESSION TAG SEQADV 3D4Q ARG A 422 UNP P15056 EXPRESSION TAG SEQADV 3D4Q GLY A 423 UNP P15056 EXPRESSION TAG SEQADV 3D4Q SER A 424 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS A 425 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS A 426 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS A 427 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS A 428 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS A 429 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS A 430 UNP P15056 EXPRESSION TAG SEQADV 3D4Q GLY A 431 UNP P15056 EXPRESSION TAG SEQADV 3D4Q SER A 432 UNP P15056 EXPRESSION TAG SEQADV 3D4Q MET B 420 UNP P15056 EXPRESSION TAG SEQADV 3D4Q ASP B 421 UNP P15056 EXPRESSION TAG SEQADV 3D4Q ARG B 422 UNP P15056 EXPRESSION TAG SEQADV 3D4Q GLY B 423 UNP P15056 EXPRESSION TAG SEQADV 3D4Q SER B 424 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS B 425 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS B 426 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS B 427 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS B 428 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS B 429 UNP P15056 EXPRESSION TAG SEQADV 3D4Q HIS B 430 UNP P15056 EXPRESSION TAG SEQADV 3D4Q GLY B 431 UNP P15056 EXPRESSION TAG SEQADV 3D4Q SER B 432 UNP P15056 EXPRESSION TAG SEQRES 1 A 307 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 A 307 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 A 307 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 A 307 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 A 307 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 A 307 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 A 307 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 A 307 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 A 307 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 A 307 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 A 307 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 A 307 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 A 307 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 A 307 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 15 A 307 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 A 307 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 A 307 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 A 307 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 A 307 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 A 307 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 A 307 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 A 307 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 A 307 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 A 307 ARG SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 307 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 B 307 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 B 307 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 B 307 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 B 307 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 B 307 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 B 307 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 B 307 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 B 307 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 B 307 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 B 307 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 B 307 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 B 307 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 B 307 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 15 B 307 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 B 307 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 B 307 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 B 307 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 B 307 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 B 307 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 B 307 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 B 307 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 B 307 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 B 307 ARG SER LEU PRO LYS ILE HIS ARG HET SM5 A 1 28 HET SM5 B 1 28 HETNAM SM5 (1E)-5-(1-PIPERIDIN-4-YL-3-PYRIDIN-4-YL-1H-PYRAZOL-4- HETNAM 2 SM5 YL)-2,3-DIHYDRO-1H-INDEN-1-ONE OXIME FORMUL 3 SM5 2(C22 H23 N5 O) FORMUL 5 HOH *23(H2 O) HELIX 1 1 THR A 491 ARG A 506 1 16 HELIX 2 2 SER A 536 ILE A 543 1 8 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 GLU A 586 LEU A 588 5 3 HELIX 5 5 ALA A 621 ARG A 626 1 6 HELIX 6 6 SER A 634 GLY A 652 1 19 HELIX 7 7 ASN A 661 ARG A 671 1 11 HELIX 8 8 ASP A 677 VAL A 681 5 5 HELIX 9 9 PRO A 686 LEU A 697 1 12 HELIX 10 10 LYS A 700 ARG A 704 5 5 HELIX 11 11 LEU A 706 SER A 720 1 15 HELIX 12 12 THR B 491 ARG B 506 1 16 HELIX 13 13 SER B 536 ILE B 543 1 8 HELIX 14 14 GLU B 549 LYS B 570 1 22 HELIX 15 15 GLU B 586 LEU B 588 5 3 HELIX 16 16 ALA B 621 ARG B 626 1 6 HELIX 17 17 SER B 634 GLY B 652 1 19 HELIX 18 18 ASN B 661 GLY B 672 1 12 HELIX 19 19 ASP B 677 VAL B 681 5 5 HELIX 20 20 PRO B 686 LEU B 697 1 12 HELIX 21 21 LYS B 700 ARG B 704 5 5 HELIX 22 22 LEU B 706 SER B 720 1 15 SHEET 1 A 5 THR A 458 GLY A 466 0 SHEET 2 A 5 GLY A 469 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 A 5 ASP A 479 MET A 484 -1 O VAL A 482 N TYR A 472 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 A 5 PHE A 516 SER A 520 -1 N MET A 517 O VAL A 528 SHEET 1 B 2 ILE A 582 HIS A 585 0 SHEET 2 B 2 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 C 5 THR B 458 GLY B 466 0 SHEET 2 C 5 GLY B 469 LYS B 475 -1 O VAL B 471 N GLY B 464 SHEET 3 C 5 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 4 C 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 C 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583 SITE 1 AC1 11 ILE A 463 GLY A 464 SER A 465 ALA A 481 SITE 2 AC1 11 LYS A 483 GLU A 501 TRP A 531 CYS A 532 SITE 3 AC1 11 PHE A 583 ASP A 594 TYR B 673 SITE 1 AC2 11 ILE B 463 GLY B 464 SER B 465 ALA B 481 SITE 2 AC2 11 LYS B 483 GLU B 501 GLN B 530 TRP B 531 SITE 3 AC2 11 CYS B 532 PHE B 583 ASP B 594 CRYST1 100.343 100.343 162.536 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009966 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009966 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006152 0.00000